BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30973932)

  • 1. Identification of two distinct hereditary hemorrhagic telangiectasia patient subsets with different hepatic perfusion properties by combination of contrast-enhanced ultrasound (CEUS) with perfusion imaging quantification.
    Schelker RC; Andorfer K; Putz F; Herr W; Jung EM
    PLoS One; 2019; 14(4):e0215178. PubMed ID: 30973932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macro- and microcirculation patterns of intrahepatic blood flow changes in patients with hereditary hemorrhagic telangiectasia.
    Schelker RC; Barreiros AP; Hart C; Herr W; Jung EM
    World J Gastroenterol; 2017 Jan; 23(3):486-495. PubMed ID: 28210085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic liver disease: Quantitative MRI vs CEUS-based microperfusion.
    Haimerl M; Poelsterl S; Beyer LP; Wiesinger I; Nießen C; Stroszczynski C; Wiggermann P; Jung EM
    Clin Hemorheol Microcirc; 2016; 64(3):435-446. PubMed ID: 27858703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Color Coded Perfusion Imaging with Contrast Enhanced Ultrasound (CEUS) for Post-Interventional Success Control Following Irreversible Electroporation (IRE) of Primary and Secondary Malignant Liver Lesions.
    Rennert J; Wiesinger I; Schicho A; Wiggermann P; Stroszczynski C; Beyer LP; Jung EM
    J Gastrointestin Liver Dis; 2019 Sep; 28(3):311-318. PubMed ID: 31517328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Color coded perfusion analysis and microcirculation imaging with contrast enhanced ultrasound (CEUS) for post-interventional success control following thermal ablative techniques of primary and secondary liver malignancies.
    Rennert J; Wiesinger I; Beyer LP; Schicho A; Stroszczynski C; Wiggermann P; Jung EM
    Clin Hemorheol Microcirc; 2019; 73(1):73-83. PubMed ID: 31561352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abdominal manifestations of hereditary hemorrhagic telangiectasia: a series of 333 patients over 15 years.
    Welle CL; Welch BT; Brinjikji W; Ehman EC; Venkatesh SK; Johnson MP; Iyer VN; Leise MD; Wood CP
    Abdom Radiol (NY); 2019 Jul; 44(7):2384-2391. PubMed ID: 30888464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative evaluation of real-time maximum liver capacity (LiMAx) and time intensity curve (TIC) analysis in CEUS-based microperfusion.
    Haimerl M; Brünn K; Poelsterl S; Beyer LP; Wiesinger I; Stroszczynski C; Jung EM; Wiggermann P
    Clin Hemorheol Microcirc; 2017; 67(3-4):373-382. PubMed ID: 28885204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative perfusion analysis of hepatocellular carcinoma using dynamic contrast enhanced ultrasound (CEUS) to determine tumor microvascularization.
    Schaible J; Stroszczynski C; Beyer LP; Jung EM
    Clin Hemorheol Microcirc; 2019; 73(1):95-104. PubMed ID: 31561349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic and pancreatic involvement in hereditary hemorrhagic telangiectasia: quantitative and qualitative evaluation with 64-section CT in asymptomatic adult patients.
    Barral M; Sirol M; Placé V; Hamzi L; Borsik M; Gayat E; Boudiaf M; Soyer P
    Eur Radiol; 2012 Jan; 22(1):161-70. PubMed ID: 21861188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary hemorrhagic telangiectasia: how to efficiently detect hepatic abnormalities using ultrasonography.
    Naganuma H; Ishida H; Kuroda H; Suzuki Y; Ogawa M
    J Med Ultrason (2001); 2020 Jul; 47(3):421-433. PubMed ID: 32390074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of patients with hereditary hemorrhagic telangiectasia and severe hepatic involvement after orthotopic liver transplantation: a single-center study.
    Dupuis-Girod S; Chesnais AL; Ginon I; Dumortier J; Saurin JC; Finet G; Decullier E; Marion D; Plauchu H; Boillot O
    Liver Transpl; 2010 Mar; 16(3):340-7. PubMed ID: 20209594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of portal vein tumor thrombosis in quantitative perfusion analysis of contrast-enhanced ultrasound of hepatocellular carcinoma.
    Wang Z; Liu G; Lu MD; Xie X; Kuang M; Wang W; Xu Z; Lin M; Chen L
    Ultrasound Med Biol; 2015 May; 41(5):1277-86. PubMed ID: 25623820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Image fusion of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) using volume navigation for detection, characterization and planning of therapeutic interventions of liver tumors.
    Rennert J; Georgieva M; Schreyer AG; Jung W; Ross C; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2011; 49(1-4):67-81. PubMed ID: 22214679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic perfusion parameters of contrast-enhanced ultrasonography correlate with the severity of chronic liver disease.
    Liu D; Qian L; Wang J; Hu X; Qiu L
    Ultrasound Med Biol; 2014 Nov; 40(11):2556-63. PubMed ID: 25218453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doppler ultrasonographic grading of hepatic vascular malformations in hereditary hemorrhagic telangiectasia -- results of extensive screening.
    Buscarini E; Danesino C; Olivieri C; Lupinacci G; De Grazia F; Reduzzi L; Blotta P; Gazzaniga P; Pagella F; Grosso M; Pongiglione G; Buscarini L; Plauchu H; Zambelli A
    Ultraschall Med; 2004 Sep; 25(5):348-55. PubMed ID: 15368138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Color coded perfusion imaging with contrast enhanced ultrasound (CEUS) for post-interventional success control following trans-arterial chemoembolization (TACE) of hepatocellular carcinoma.
    Rennert J; Wiesinger I; Schicho A; Beyer LP; Wiggermann P; Stroszczynski C; Jung EM
    PLoS One; 2019; 14(6):e0217599. PubMed ID: 31181127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-enhanced ultrasonography for the evaluation of liver fibrosis after biliary obstruction.
    Shin HJ; Chang EY; Lee HS; Hong JH; Park G; Kim HG; Kim MJ; Lee MJ
    World J Gastroenterol; 2015 Mar; 21(9):2614-21. PubMed ID: 25759528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of dynamic contrast-enhanced ultrasound (CEUS) in non-cystic breast lesions using external perfusion software.
    Jung EM; Jung F; Stroszczynski C; Wiesinger I
    Sci Rep; 2021 Sep; 11(1):17677. PubMed ID: 34480040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VueBox® perfusion analysis of contrast-enhanced ultrasound (CEUS) examinations in patients with primary hyperparathyroidism for preoperative detection of parathyroid gland adenoma.
    Platz Batista da Silva N; Jung EM; Jung F; Schlitt HJ; Hornung M
    Clin Hemorheol Microcirc; 2018; 70(4):423-431. PubMed ID: 30347604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative evaluation of microvascularization in mandibular reconstructions with microvascular flaps - first results with a new perfusion software for contrast-enhanced sonography (CEUS).
    Mueller S; Gosau M; Wendl CM; Prantl L; Wiggermann P; Reichert TE; Jung EM
    Clin Hemorheol Microcirc; 2012; 52(2-4):187-96. PubMed ID: 22960301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.